Definitive Contract VA24017C0100
Award Date 9/18/17
Potential Completion Date 9/17/20
Potential Value $440K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a definitive contract awarded by the U.S. Department of Veterans Affairs (VA) to The University of Texas M.D. Anderson Cancer Center (MD Anderson) for the peer review of radiation quality assurance operations. The contract has a firm fixed price of $989,135.00 and a completion date of September 29, 2018. MD Anderson is a comprehensive cancer treatment and research center that has received numerous prime and subcontract awards from federal agencies, including the National Institutes of...
- This is a prime contract awarded by the U.S. government to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is for $6,155,674.00 and is a Definitive Contract with Cost No Fee pricing. The place of performance is Texas, USA. The contract is for biomedical (applied/exploratory) services and does not have a set-aside designation. MD Anderson Cancer Center, a comprehensive cancer treatment and research center, has received this prime...
- This is a three-year, $13,481,325.00 definitive contract awarded by the National Cancer Institute (NCI) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract supports a Phase II chemoprevention clinical trial in patients with adenomatous polyposis coli, a genetic condition that increases cancer risk. The contract does not have a small business set-aside designation. MD Anderson Cancer Center, a comprehensive cancer research and...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson) in the amount of $400,411.43. The contract was issued under the PREVENT Cancer Program (PREVENT) contract vehicle and supports the PRECLINICAL PREVENT CANCER PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS project with a period of performance through...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract for $150,904.40 to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for an "Invasive Mold Data Acquisition" project. The contract does not have a set-aside designation and was awarded on July 15, 2019, with a completion date of July 14, 2020. MD Anderson Cancer Center is a comprehensive cancer treatment...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is part of the PREVENT Cancer Program, a preclinical research initiative focused on developing prevention strategies for breast cancer. The $714,123.60 contract supports "TARGETING THE MTOR PATHWAY FOR THE PREVENTION OF...
- This is a modification to a federal contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson). The original contract was a definitive cost-no-fee contract awarded on February 15, 2003 with a ceiling value of $8,606,292. This modification is to deobligate FY06 funds. MD Anderson, a U.S. state government entity and academic medical center, has been the prime contractor as...
- This federal contract was awarded by the Department of Health and Human Services' Food and Drug Administration to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract, valued at $283,546.12, is for a study titled "Modular Application of Surface Technology for the Generation of Antigen-Specific T Cells." It is a definitive contract with a cost-no-fee pricing type, awarded on September 13, 2019 with a completion date of...
- This is a delivery order awarded by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson) for $591,907.50. The order is part of the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract, which facilitates the provision of tissue samples and data from various cancer types to support the Cancer Genome Atlas (TCGA) program. This work is funded through the American Recovery and Reinvestment Act (ARRA). The delivery order does...
- This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson) in support of the Cancer Genome Atlas (TCGA) program. The $146,302 firm fixed price delivery order contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ vehicle. The contract requires MD Anderson, a large academic cancer center, to provide tissue samples and data from...